Judging Success in Translational Medical Research
Getting promising drug discoveries out of university labs and into the drug pipeline is more difficult than it should be.
Getting promising drug discoveries out of university labs and into the drug pipeline is more difficult than it should be.
In the world that's now emerging, pre-modern practices that emphasize personal relationships are returning to prominence.
The disruptive force of the "new philanthropy" holds the promise of helping to reduce inequality. But will it actually do so?
Environmental conservation and business investment are not mutually exclusive, argues the CEO of the Nature Conservancy.
Where levels of workplace diversity are higher than average, the level of charitable giving also tends to be higher.
Protest movements don't emerge merely because people have something to protest. Many other factors come into play.
Racial integration in US schools has declined in the wake of recent court decisions to release districts from earlier desegregation orders.
Political reform alone doesn't ensure good government. Equally important, if not more so, are institutions that let citizens act collectively.
Public sector innovators are improving government by replicating the market conditions that have fostered breakthroughs in the private sector.
Growing numbers of foundations, government agencies, and corporations in Europe are adopting venture philanthropy practices.